Fc fusion molecules and uses thereof
US12091694B2 · kind B2 · utility
0Cited by
17References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2023 |
| Grant date | Sep 17, 2024 |
| Priority date | — |
| Expiry date | Nov 17, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Embodiments provided herein, provide for polypeptides and molecules comprising a polypeptide having protease activity and a variant Fc molecule, pharmaceutical compositions comprising the same, and methods that can be used to treat disorders, such as IgG mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.